nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—CES1—Capecitabine—esophageal cancer	0.242	0.322	CbGbCtD
L-Carnitine—XDH—Carboplatin—esophageal cancer	0.123	0.164	CbGbCtD
L-Carnitine—MPO—Carboplatin—esophageal cancer	0.123	0.164	CbGbCtD
L-Carnitine—MPO—Cisplatin—esophageal cancer	0.105	0.14	CbGbCtD
L-Carnitine—XDH—Cisplatin—esophageal cancer	0.105	0.14	CbGbCtD
L-Carnitine—SLCO1B1—Methotrexate—esophageal cancer	0.0272	0.0362	CbGbCtD
L-Carnitine—SLC22A8—Methotrexate—esophageal cancer	0.0251	0.0334	CbGbCtD
L-Carnitine—CES1—larynx—esophageal cancer	0.00833	0.0886	CbGeAlD
L-Carnitine—SLC22A4—larynx—esophageal cancer	0.00635	0.0676	CbGeAlD
L-Carnitine—SLC25A29—neck—esophageal cancer	0.00624	0.0664	CbGeAlD
L-Carnitine—SLC25A29—bronchus—esophageal cancer	0.00418	0.0445	CbGeAlD
L-Carnitine—CROT—bronchus—esophageal cancer	0.00384	0.0408	CbGeAlD
L-Carnitine—CROT—smooth muscle tissue—esophageal cancer	0.00375	0.0399	CbGeAlD
L-Carnitine—SLC25A20—bronchus—esophageal cancer	0.00334	0.0355	CbGeAlD
L-Carnitine—Fluid overload—Carboplatin—esophageal cancer	0.00327	0.118	CcSEcCtD
L-Carnitine—CRAT—bronchus—esophageal cancer	0.00324	0.0345	CbGeAlD
L-Carnitine—CRAT—smooth muscle tissue—esophageal cancer	0.00317	0.0337	CbGeAlD
L-Carnitine—SLC25A20—trachea—esophageal cancer	0.003	0.0319	CbGeAlD
L-Carnitine—CRAT—trachea—esophageal cancer	0.00291	0.0309	CbGeAlD
L-Carnitine—SLC25A29—lung—esophageal cancer	0.0027	0.0287	CbGeAlD
L-Carnitine—Choline—PDE4D—esophageal cancer	0.00261	1	CrCbGaD
L-Carnitine—CPT2—bronchus—esophageal cancer	0.00249	0.0265	CbGeAlD
L-Carnitine—CROT—lung—esophageal cancer	0.00248	0.0263	CbGeAlD
L-Carnitine—CES1—neck—esophageal cancer	0.00221	0.0235	CbGeAlD
L-Carnitine—SLC25A20—lung—esophageal cancer	0.00215	0.0229	CbGeAlD
L-Carnitine—CRAT—lung—esophageal cancer	0.00209	0.0222	CbGeAlD
L-Carnitine—CPT1A—digestive system—esophageal cancer	0.00203	0.0216	CbGeAlD
L-Carnitine—SLC25A29—lymph node—esophageal cancer	0.00185	0.0196	CbGeAlD
L-Carnitine—CPT1A—lung—esophageal cancer	0.00169	0.018	CbGeAlD
L-Carnitine—CROT—lymph node—esophageal cancer	0.00169	0.018	CbGeAlD
L-Carnitine—SLC22A4—neck—esophageal cancer	0.00168	0.0179	CbGeAlD
L-Carnitine—CPT2—lung—esophageal cancer	0.00161	0.0171	CbGeAlD
L-Carnitine—XDH—digestive system—esophageal cancer	0.0015	0.0159	CbGeAlD
L-Carnitine—SLC25A20—lymph node—esophageal cancer	0.00147	0.0157	CbGeAlD
L-Carnitine—CRAT—lymph node—esophageal cancer	0.00143	0.0152	CbGeAlD
L-Carnitine—MPO—epithelium—esophageal cancer	0.00125	0.0133	CbGeAlD
L-Carnitine—CPT1A—lymph node—esophageal cancer	0.00116	0.0123	CbGeAlD
L-Carnitine—CES1—digestive system—esophageal cancer	0.00114	0.0122	CbGeAlD
L-Carnitine—SLC22A4—bronchus—esophageal cancer	0.00113	0.012	CbGeAlD
L-Carnitine—CPT2—lymph node—esophageal cancer	0.0011	0.0117	CbGeAlD
L-Carnitine—SLC22A4—trachea—esophageal cancer	0.00101	0.0108	CbGeAlD
L-Carnitine—SLCO1B1—digestive system—esophageal cancer	0.000982	0.0104	CbGeAlD
L-Carnitine—Fluid overload—Cisplatin—esophageal cancer	0.000958	0.0347	CcSEcCtD
L-Carnitine—CES1—lung—esophageal cancer	0.000954	0.0102	CbGeAlD
L-Carnitine—MPO—digestive system—esophageal cancer	0.000954	0.0102	CbGeAlD
L-Carnitine—SLC22A4—digestive system—esophageal cancer	0.000871	0.00927	CbGeAlD
L-Carnitine—MPO—lung—esophageal cancer	0.000797	0.00848	CbGeAlD
L-Carnitine—SLC22A5—bronchus—esophageal cancer	0.000746	0.00794	CbGeAlD
L-Carnitine—SLC22A4—lung—esophageal cancer	0.000728	0.00774	CbGeAlD
L-Carnitine—Infection—Carboplatin—esophageal cancer	0.00072	0.0261	CcSEcCtD
L-Carnitine—SLC22A5—trachea—esophageal cancer	0.00067	0.00713	CbGeAlD
L-Carnitine—CES1—lymph node—esophageal cancer	0.000653	0.00695	CbGeAlD
L-Carnitine—Hypercalcaemia—Capecitabine—esophageal cancer	0.000632	0.0229	CcSEcCtD
L-Carnitine—Pain—Carboplatin—esophageal cancer	0.00062	0.0225	CcSEcCtD
L-Carnitine—Hyperkalaemia—Cisplatin—esophageal cancer	0.000585	0.0212	CcSEcCtD
L-Carnitine—SLC22A5—digestive system—esophageal cancer	0.000577	0.00614	CbGeAlD
L-Carnitine—Body temperature increased—Carboplatin—esophageal cancer	0.000573	0.0208	CcSEcCtD
L-Carnitine—MPO—lymph node—esophageal cancer	0.000545	0.0058	CbGeAlD
L-Carnitine—SLC22A4—lymph node—esophageal cancer	0.000498	0.0053	CbGeAlD
L-Carnitine—SLC22A5—lung—esophageal cancer	0.000482	0.00512	CbGeAlD
L-Carnitine—Injection site reaction—Capecitabine—esophageal cancer	0.000437	0.0158	CcSEcCtD
L-Carnitine—Melaena—Capecitabine—esophageal cancer	0.000429	0.0155	CcSEcCtD
L-Carnitine—Atrial fibrillation—Capecitabine—esophageal cancer	0.000336	0.0122	CcSEcCtD
L-Carnitine—SLC22A5—lymph node—esophageal cancer	0.000329	0.0035	CbGeAlD
L-Carnitine—Renal failure—Cisplatin—esophageal cancer	0.000328	0.0119	CcSEcCtD
L-Carnitine—Melaena—Methotrexate—esophageal cancer	0.000319	0.0116	CcSEcCtD
L-Carnitine—Gastritis—Capecitabine—esophageal cancer	0.000282	0.0102	CcSEcCtD
L-Carnitine—Muscular weakness—Capecitabine—esophageal cancer	0.000281	0.0102	CcSEcCtD
L-Carnitine—Eye disorder—Cisplatin—esophageal cancer	0.00028	0.0101	CcSEcCtD
L-Carnitine—Influenza—Capecitabine—esophageal cancer	0.000275	0.00998	CcSEcCtD
L-Carnitine—Arrhythmia—Cisplatin—esophageal cancer	0.000267	0.00968	CcSEcCtD
L-Carnitine—Bronchitis—Capecitabine—esophageal cancer	0.000265	0.0096	CcSEcCtD
L-Carnitine—Weight increased—Capecitabine—esophageal cancer	0.000251	0.00909	CcSEcCtD
L-Carnitine—Muscle spasms—Cisplatin—esophageal cancer	0.00025	0.00907	CcSEcCtD
L-Carnitine—Weight decreased—Capecitabine—esophageal cancer	0.000249	0.00903	CcSEcCtD
L-Carnitine—Depression—Capecitabine—esophageal cancer	0.000245	0.00888	CcSEcCtD
L-Carnitine—Renal failure—Capecitabine—esophageal cancer	0.000241	0.00875	CcSEcCtD
L-Carnitine—Anaemia—Cisplatin—esophageal cancer	0.000241	0.00872	CcSEcCtD
L-Carnitine—Urinary tract infection—Capecitabine—esophageal cancer	0.000239	0.00865	CcSEcCtD
L-Carnitine—Convulsion—Cisplatin—esophageal cancer	0.000226	0.00818	CcSEcCtD
L-Carnitine—Myalgia—Cisplatin—esophageal cancer	0.000222	0.00803	CcSEcCtD
L-Carnitine—Haemoglobin—Capecitabine—esophageal cancer	0.000222	0.00803	CcSEcCtD
L-Carnitine—Rhinitis—Capecitabine—esophageal cancer	0.000221	0.00801	CcSEcCtD
L-Carnitine—Anxiety—Cisplatin—esophageal cancer	0.000221	0.00801	CcSEcCtD
L-Carnitine—Haemorrhage—Capecitabine—esophageal cancer	0.000221	0.00799	CcSEcCtD
L-Carnitine—Pharyngitis—Capecitabine—esophageal cancer	0.000219	0.00793	CcSEcCtD
L-Carnitine—Oedema peripheral—Capecitabine—esophageal cancer	0.000217	0.00787	CcSEcCtD
L-Carnitine—Infection—Cisplatin—esophageal cancer	0.000211	0.00765	CcSEcCtD
L-Carnitine—Tachycardia—Cisplatin—esophageal cancer	0.000207	0.00752	CcSEcCtD
L-Carnitine—Eye disorder—Capecitabine—esophageal cancer	0.000206	0.00747	CcSEcCtD
L-Carnitine—Anorexia—Cisplatin—esophageal cancer	0.000203	0.00734	CcSEcCtD
L-Carnitine—Angiopathy—Capecitabine—esophageal cancer	0.0002	0.00725	CcSEcCtD
L-Carnitine—Hypotension—Cisplatin—esophageal cancer	0.000199	0.0072	CcSEcCtD
L-Carnitine—Arrhythmia—Capecitabine—esophageal cancer	0.000197	0.00714	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000194	0.00702	CcSEcCtD
L-Carnitine—Paraesthesia—Cisplatin—esophageal cancer	0.000191	0.00692	CcSEcCtD
L-Carnitine—Dyspnoea—Cisplatin—esophageal cancer	0.000189	0.00687	CcSEcCtD
L-Carnitine—Dysgeusia—Capecitabine—esophageal cancer	0.000188	0.00681	CcSEcCtD
L-Carnitine—Back pain—Capecitabine—esophageal cancer	0.000186	0.00673	CcSEcCtD
L-Carnitine—Decreased appetite—Cisplatin—esophageal cancer	0.000185	0.00669	CcSEcCtD
L-Carnitine—Muscle spasms—Capecitabine—esophageal cancer	0.000185	0.00669	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000183	0.00665	CcSEcCtD
L-Carnitine—Depression—Methotrexate—esophageal cancer	0.000182	0.00661	CcSEcCtD
L-Carnitine—Pain—Cisplatin—esophageal cancer	0.000182	0.00659	CcSEcCtD
L-Carnitine—Renal failure—Methotrexate—esophageal cancer	0.00018	0.00651	CcSEcCtD
L-Carnitine—Anaemia—Capecitabine—esophageal cancer	0.000177	0.00643	CcSEcCtD
L-Carnitine—Vertigo—Capecitabine—esophageal cancer	0.000172	0.00625	CcSEcCtD
L-Carnitine—Palpitations—Capecitabine—esophageal cancer	0.00017	0.00615	CcSEcCtD
L-Carnitine—Body temperature increased—Cisplatin—esophageal cancer	0.000168	0.00609	CcSEcCtD
L-Carnitine—Cough—Capecitabine—esophageal cancer	0.000168	0.00607	CcSEcCtD
L-Carnitine—Hypertension—Capecitabine—esophageal cancer	0.000166	0.00601	CcSEcCtD
L-Carnitine—Haemoglobin—Methotrexate—esophageal cancer	0.000165	0.00598	CcSEcCtD
L-Carnitine—Haemorrhage—Methotrexate—esophageal cancer	0.000164	0.00595	CcSEcCtD
L-Carnitine—Chest pain—Capecitabine—esophageal cancer	0.000163	0.00592	CcSEcCtD
L-Carnitine—Myalgia—Capecitabine—esophageal cancer	0.000163	0.00592	CcSEcCtD
L-Carnitine—Pharyngitis—Methotrexate—esophageal cancer	0.000163	0.0059	CcSEcCtD
L-Carnitine—Anxiety—Capecitabine—esophageal cancer	0.000163	0.0059	CcSEcCtD
L-Carnitine—Hypersensitivity—Cisplatin—esophageal cancer	0.000157	0.00567	CcSEcCtD
L-Carnitine—Infection—Capecitabine—esophageal cancer	0.000156	0.00564	CcSEcCtD
L-Carnitine—Eye disorder—Methotrexate—esophageal cancer	0.000153	0.00556	CcSEcCtD
L-Carnitine—Tachycardia—Capecitabine—esophageal cancer	0.000153	0.00554	CcSEcCtD
L-Carnitine—Asthenia—Cisplatin—esophageal cancer	0.000152	0.00553	CcSEcCtD
L-Carnitine—Anorexia—Capecitabine—esophageal cancer	0.000149	0.00541	CcSEcCtD
L-Carnitine—Angiopathy—Methotrexate—esophageal cancer	0.000149	0.0054	CcSEcCtD
L-Carnitine—Hypotension—Capecitabine—esophageal cancer	0.000146	0.0053	CcSEcCtD
L-Carnitine—Diarrhoea—Cisplatin—esophageal cancer	0.000145	0.00527	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000143	0.00517	CcSEcCtD
L-Carnitine—Insomnia—Capecitabine—esophageal cancer	0.000142	0.00513	CcSEcCtD
L-Carnitine—Paraesthesia—Capecitabine—esophageal cancer	0.000141	0.0051	CcSEcCtD
L-Carnitine—Dysgeusia—Methotrexate—esophageal cancer	0.00014	0.00507	CcSEcCtD
L-Carnitine—Dyspnoea—Capecitabine—esophageal cancer	0.00014	0.00506	CcSEcCtD
L-Carnitine—Back pain—Methotrexate—esophageal cancer	0.000138	0.00501	CcSEcCtD
L-Carnitine—Dyspepsia—Capecitabine—esophageal cancer	0.000138	0.005	CcSEcCtD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—esophageal cancer	0.000137	0.0011	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000136	0.0011	CbGpPWpGaD
L-Carnitine—Decreased appetite—Capecitabine—esophageal cancer	0.000136	0.00493	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000135	0.0049	CcSEcCtD
L-Carnitine—Vomiting—Cisplatin—esophageal cancer	0.000135	0.0049	CcSEcCtD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000134	0.00108	CbGpPWpGaD
L-Carnitine—Rash—Cisplatin—esophageal cancer	0.000134	0.00486	CcSEcCtD
L-Carnitine—Constipation—Capecitabine—esophageal cancer	0.000134	0.00485	CcSEcCtD
L-Carnitine—Pain—Capecitabine—esophageal cancer	0.000134	0.00485	CcSEcCtD
L-Carnitine—Dermatitis—Cisplatin—esophageal cancer	0.000134	0.00485	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—PTGS2—esophageal cancer	0.000134	0.00107	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SLC52A3—esophageal cancer	0.000132	0.00106	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—ALDH2—esophageal cancer	0.000132	0.00106	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—ALDH2—esophageal cancer	0.000132	0.00106	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—BLVRB—esophageal cancer	0.000132	0.00106	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000132	0.00106	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000132	0.00106	CbGpPWpGaD
L-Carnitine—Anaemia—Methotrexate—esophageal cancer	0.000132	0.00479	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—EP300—esophageal cancer	0.000132	0.00106	CbGpPWpGaD
L-Carnitine—Vertigo—Methotrexate—esophageal cancer	0.000128	0.00465	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000128	0.00464	CcSEcCtD
L-Carnitine—Nausea—Cisplatin—esophageal cancer	0.000126	0.00457	CcSEcCtD
L-Carnitine—CRAT—Metabolism—GSTT1—esophageal cancer	0.000126	0.00101	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GSTT1—esophageal cancer	0.000126	0.00101	CbGpPWpGaD
L-Carnitine—Cough—Methotrexate—esophageal cancer	0.000125	0.00452	CcSEcCtD
L-Carnitine—CRAT—Metabolism—CYP2A6—esophageal cancer	0.000124	0.001	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CYP2A6—esophageal cancer	0.000124	0.001	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000124	0.000997	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000124	0.000997	CbGpPWpGaD
L-Carnitine—Abdominal pain—Capecitabine—esophageal cancer	0.000124	0.00449	CcSEcCtD
L-Carnitine—Body temperature increased—Capecitabine—esophageal cancer	0.000124	0.00449	CcSEcCtD
L-Carnitine—Convulsion—Methotrexate—esophageal cancer	0.000124	0.00449	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000122	0.000981	CbGpPWpGaD
L-Carnitine—Chest pain—Methotrexate—esophageal cancer	0.000122	0.00441	CcSEcCtD
L-Carnitine—Myalgia—Methotrexate—esophageal cancer	0.000122	0.00441	CcSEcCtD
L-Carnitine—CPT2—Metabolism—ADH1B—esophageal cancer	0.000121	0.000973	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000119	0.00096	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000118	0.000951	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTGS1—esophageal cancer	0.000118	0.000949	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTGS1—esophageal cancer	0.000118	0.000949	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—ENO1—esophageal cancer	0.000118	0.000949	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—ENO1—esophageal cancer	0.000118	0.000949	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CYP1B1—esophageal cancer	0.000118	0.000949	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PSME1—esophageal cancer	0.000116	0.000935	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PSME1—esophageal cancer	0.000116	0.000935	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PSME2—esophageal cancer	0.000116	0.000935	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PSME2—esophageal cancer	0.000116	0.000935	CbGpPWpGaD
L-Carnitine—Infection—Methotrexate—esophageal cancer	0.000116	0.0042	CcSEcCtD
L-Carnitine—CPT2—Metabolism—TYMP—esophageal cancer	0.000116	0.00093	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Capecitabine—esophageal cancer	0.000115	0.00418	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—MYC—esophageal cancer	0.000115	0.000925	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000115	0.000922	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—TP53—esophageal cancer	0.000115	0.000921	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SLC10A2—esophageal cancer	0.000112	0.000905	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CA1—esophageal cancer	0.000112	0.000905	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYP26A1—esophageal cancer	0.000112	0.000905	CbGpPWpGaD
L-Carnitine—Asthenia—Capecitabine—esophageal cancer	0.000112	0.00407	CcSEcCtD
L-Carnitine—Anorexia—Methotrexate—esophageal cancer	0.000111	0.00403	CcSEcCtD
L-Carnitine—CROT—Metabolism—CYP19A1—esophageal cancer	0.000111	0.000892	CbGpPWpGaD
L-Carnitine—Pruritus—Capecitabine—esophageal cancer	0.000111	0.00402	CcSEcCtD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00011	0.000887	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ALOX15—esophageal cancer	0.00011	0.000882	CbGpPWpGaD
L-Carnitine—Hypotension—Methotrexate—esophageal cancer	0.000109	0.00395	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000109	0.000874	CbGpPWpGaD
L-Carnitine—Diarrhoea—Capecitabine—esophageal cancer	0.000107	0.00388	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000106	0.00385	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000106	0.000854	CbGpPWpGaD
L-Carnitine—Insomnia—Methotrexate—esophageal cancer	0.000105	0.00382	CcSEcCtD
L-Carnitine—Paraesthesia—Methotrexate—esophageal cancer	0.000105	0.00379	CcSEcCtD
L-Carnitine—CPT2—Metabolism—TPI1—esophageal cancer	0.000105	0.000841	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GSTO1—esophageal cancer	0.000105	0.000841	CbGpPWpGaD
L-Carnitine—Dyspnoea—Methotrexate—esophageal cancer	0.000104	0.00377	CcSEcCtD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000104	0.000834	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000104	0.000834	CbGpPWpGaD
L-Carnitine—Dizziness—Capecitabine—esophageal cancer	0.000104	0.00375	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—CA2—esophageal cancer	0.000103	0.000828	CbGpPWpGaD
L-Carnitine—Dyspepsia—Methotrexate—esophageal cancer	0.000103	0.00372	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000101	0.000816	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000101	0.000816	CbGpPWpGaD
L-Carnitine—Decreased appetite—Methotrexate—esophageal cancer	0.000101	0.00367	CcSEcCtD
L-Carnitine—CROT—Metabolism—HMOX1—esophageal cancer	0.000101	0.000814	CbGpPWpGaD
L-Carnitine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000101	0.00365	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000101	0.000809	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CYP1B1—esophageal cancer	0.0001	0.000807	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CYP1B1—esophageal cancer	0.0001	0.000807	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ALDOB—esophageal cancer	0.0001	0.000807	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.0001	0.000806	CbGpPWpGaD
L-Carnitine—Pain—Methotrexate—esophageal cancer	9.97e-05	0.00361	CcSEcCtD
L-Carnitine—Vomiting—Capecitabine—esophageal cancer	9.96e-05	0.00361	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ATP4A—esophageal cancer	9.94e-05	0.0008	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	9.94e-05	0.0008	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.92e-05	0.000798	CbGpPWpGaD
L-Carnitine—Rash—Capecitabine—esophageal cancer	9.88e-05	0.00358	CcSEcCtD
L-Carnitine—Dermatitis—Capecitabine—esophageal cancer	9.87e-05	0.00358	CcSEcCtD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	9.83e-05	0.000791	CbGpPWpGaD
L-Carnitine—Headache—Capecitabine—esophageal cancer	9.81e-05	0.00356	CcSEcCtD
L-Carnitine—CROT—Metabolism—ABCB1—esophageal cancer	9.71e-05	0.000781	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GAPDH—esophageal cancer	9.65e-05	0.000776	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—CREBBP—esophageal cancer	9.6e-05	0.000773	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ADH7—esophageal cancer	9.56e-05	0.000769	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PLCE1—esophageal cancer	9.56e-05	0.000769	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CRABP1—esophageal cancer	9.56e-05	0.000769	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Methotrexate—esophageal cancer	9.54e-05	0.00346	CcSEcCtD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—esophageal cancer	9.47e-05	0.000761	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	9.45e-05	0.000761	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CYP19A1—esophageal cancer	9.43e-05	0.000758	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CYP19A1—esophageal cancer	9.43e-05	0.000758	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—AQP3—esophageal cancer	9.38e-05	0.000754	CbGpPWpGaD
L-Carnitine—Nausea—Capecitabine—esophageal cancer	9.31e-05	0.00337	CcSEcCtD
L-Carnitine—Body temperature increased—Methotrexate—esophageal cancer	9.22e-05	0.00334	CcSEcCtD
L-Carnitine—Abdominal pain—Methotrexate—esophageal cancer	9.22e-05	0.00334	CcSEcCtD
L-Carnitine—CPT2—Metabolism—GNG7—esophageal cancer	9.1e-05	0.000732	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—GNG7—esophageal cancer	9.09e-05	0.000732	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	8.99e-05	0.000723	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ATP4A—esophageal cancer	8.99e-05	0.000723	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	8.81e-05	0.000708	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC52A3—esophageal cancer	8.76e-05	0.000705	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—BLVRB—esophageal cancer	8.76e-05	0.000705	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—EP300—esophageal cancer	8.67e-05	0.000697	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—HMOX1—esophageal cancer	8.6e-05	0.000692	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—HMOX1—esophageal cancer	8.6e-05	0.000692	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Methotrexate—esophageal cancer	8.59e-05	0.00311	CcSEcCtD
L-Carnitine—CPT2—Metabolism—ALDH2—esophageal cancer	8.53e-05	0.000686	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.44e-05	0.000679	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.44e-05	0.000679	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ADH1B—esophageal cancer	8.39e-05	0.000675	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	8.37e-05	0.000674	CbGpPWpGaD
L-Carnitine—Asthenia—Methotrexate—esophageal cancer	8.37e-05	0.00303	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—ABCB1—esophageal cancer	8.26e-05	0.000664	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—ABCB1—esophageal cancer	8.26e-05	0.000664	CbGpPWpGaD
L-Carnitine—Pruritus—Methotrexate—esophageal cancer	8.25e-05	0.00299	CcSEcCtD
L-Carnitine—CPT2—Metabolism—GSTT1—esophageal cancer	8.11e-05	0.000652	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—TYMP—esophageal cancer	8.02e-05	0.000645	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYP2A6—esophageal cancer	8.02e-05	0.000645	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.98e-05	0.000642	CbGpPWpGaD
L-Carnitine—Diarrhoea—Methotrexate—esophageal cancer	7.98e-05	0.00289	CcSEcCtD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	7.87e-05	0.000633	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP26A1—esophageal cancer	7.8e-05	0.000627	CbGpPWpGaD
L-Carnitine—Dizziness—Methotrexate—esophageal cancer	7.71e-05	0.00279	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—ALOX15—esophageal cancer	7.6e-05	0.000611	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTGS1—esophageal cancer	7.6e-05	0.000611	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ENO1—esophageal cancer	7.6e-05	0.000611	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ABCC2—esophageal cancer	7.53e-05	0.000606	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PSME1—esophageal cancer	7.49e-05	0.000602	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PSME2—esophageal cancer	7.49e-05	0.000602	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	7.46e-05	0.0006	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC10A2—esophageal cancer	7.45e-05	0.000599	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CA1—esophageal cancer	7.45e-05	0.000599	CbGpPWpGaD
L-Carnitine—Vomiting—Methotrexate—esophageal cancer	7.42e-05	0.00269	CcSEcCtD
L-Carnitine—Rash—Methotrexate—esophageal cancer	7.35e-05	0.00266	CcSEcCtD
L-Carnitine—Dermatitis—Methotrexate—esophageal cancer	7.35e-05	0.00266	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.34e-05	0.000591	CbGpPWpGaD
L-Carnitine—Headache—Methotrexate—esophageal cancer	7.31e-05	0.00265	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—TPI1—esophageal cancer	7.25e-05	0.000583	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTO1—esophageal cancer	7.25e-05	0.000583	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—AQP3—esophageal cancer	7.12e-05	0.000573	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ALDOB—esophageal cancer	6.95e-05	0.000559	CbGpPWpGaD
L-Carnitine—Nausea—Methotrexate—esophageal cancer	6.93e-05	0.00251	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—GNG7—esophageal cancer	6.84e-05	0.00055	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	6.83e-05	0.000549	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	6.83e-05	0.000549	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CA2—esophageal cancer	6.82e-05	0.000548	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ABCC2—esophageal cancer	6.81e-05	0.000548	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GAPDH—esophageal cancer	6.69e-05	0.000538	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CRABP1—esophageal cancer	6.63e-05	0.000533	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.54e-05	0.000526	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CREBBP—esophageal cancer	6.49e-05	0.000522	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYP1B1—esophageal cancer	6.46e-05	0.00052	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ADH7—esophageal cancer	6.34e-05	0.00051	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PLCE1—esophageal cancer	6.34e-05	0.00051	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GNG7—esophageal cancer	6.31e-05	0.000507	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.24e-05	0.000502	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.24e-05	0.000502	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—TP53—esophageal cancer	6.2e-05	0.000499	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—GNG7—esophageal cancer	6.18e-05	0.000497	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYP19A1—esophageal cancer	6.07e-05	0.000489	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	5.95e-05	0.000478	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ALDH2—esophageal cancer	5.91e-05	0.000475	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—NOS3—esophageal cancer	5.81e-05	0.000467	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTT1—esophageal cancer	5.62e-05	0.000452	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP2A6—esophageal cancer	5.56e-05	0.000447	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ADH1B—esophageal cancer	5.56e-05	0.000447	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—HMOX1—esophageal cancer	5.54e-05	0.000446	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.54e-05	0.000446	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.53e-05	0.000445	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CREBBP—esophageal cancer	5.52e-05	0.000444	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CREBBP—esophageal cancer	5.52e-05	0.000444	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.44e-05	0.000437	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ABCB1—esophageal cancer	5.32e-05	0.000428	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.32e-05	0.000428	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PTGS2—esophageal cancer	5.31e-05	0.000427	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—TYMP—esophageal cancer	5.31e-05	0.000427	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ENO1—esophageal cancer	5.27e-05	0.000424	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTGS1—esophageal cancer	5.27e-05	0.000424	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	5.19e-05	0.000417	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PSME2—esophageal cancer	5.19e-05	0.000417	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PSME1—esophageal cancer	5.19e-05	0.000417	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	5.17e-05	0.000416	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP26A1—esophageal cancer	5.17e-05	0.000415	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ALOX15—esophageal cancer	5.03e-05	0.000405	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—NOS3—esophageal cancer	4.94e-05	0.000397	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—NOS3—esophageal cancer	4.94e-05	0.000397	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTO1—esophageal cancer	4.8e-05	0.000386	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—TPI1—esophageal cancer	4.8e-05	0.000386	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—GNG7—esophageal cancer	4.69e-05	0.000378	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—BLVRB—esophageal cancer	4.61e-05	0.000371	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC52A3—esophageal cancer	4.61e-05	0.000371	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ALDOB—esophageal cancer	4.6e-05	0.00037	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.53e-05	0.000365	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTGS2—esophageal cancer	4.52e-05	0.000363	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTGS2—esophageal cancer	4.52e-05	0.000363	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP1B1—esophageal cancer	4.48e-05	0.00036	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GAPDH—esophageal cancer	4.43e-05	0.000356	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—EP300—esophageal cancer	4.42e-05	0.000356	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CRABP1—esophageal cancer	4.39e-05	0.000353	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP19A1—esophageal cancer	4.21e-05	0.000339	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GNG7—esophageal cancer	4.18e-05	0.000336	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.16e-05	0.000335	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	4.12e-05	0.000332	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.02e-05	0.000324	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4e-05	0.000322	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CA1—esophageal cancer	3.92e-05	0.000315	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC10A2—esophageal cancer	3.92e-05	0.000315	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ALDH2—esophageal cancer	3.91e-05	0.000315	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—HMOX1—esophageal cancer	3.84e-05	0.000309	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.77e-05	0.000303	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.77e-05	0.000303	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—EP300—esophageal cancer	3.76e-05	0.000302	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—EP300—esophageal cancer	3.76e-05	0.000302	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTT1—esophageal cancer	3.72e-05	0.000299	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ABCB1—esophageal cancer	3.69e-05	0.000297	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP2A6—esophageal cancer	3.68e-05	0.000296	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.62e-05	0.000291	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CA2—esophageal cancer	3.59e-05	0.000289	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CREBBP—esophageal cancer	3.56e-05	0.000286	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.55e-05	0.000286	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.51e-05	0.000282	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ENO1—esophageal cancer	3.49e-05	0.000281	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTGS1—esophageal cancer	3.49e-05	0.000281	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PSME1—esophageal cancer	3.44e-05	0.000277	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PSME2—esophageal cancer	3.44e-05	0.000277	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PLCE1—esophageal cancer	3.33e-05	0.000268	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ADH7—esophageal cancer	3.33e-05	0.000268	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.3e-05	0.000265	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CA—esophageal cancer	3.27e-05	0.000263	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—NOS3—esophageal cancer	3.18e-05	0.000256	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP1B1—esophageal cancer	2.97e-05	0.000239	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ADH1B—esophageal cancer	2.92e-05	0.000235	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTGS2—esophageal cancer	2.91e-05	0.000234	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.86e-05	0.00023	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—TYMP—esophageal cancer	2.79e-05	0.000225	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP19A1—esophageal cancer	2.79e-05	0.000224	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.79e-05	0.000224	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CA—esophageal cancer	2.78e-05	0.000224	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CA—esophageal cancer	2.78e-05	0.000224	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.75e-05	0.000221	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP26A1—esophageal cancer	2.72e-05	0.000219	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.67e-05	0.000215	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALOX15—esophageal cancer	2.65e-05	0.000213	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—HMOX1—esophageal cancer	2.55e-05	0.000205	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTO1—esophageal cancer	2.53e-05	0.000203	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—TPI1—esophageal cancer	2.53e-05	0.000203	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CREBBP—esophageal cancer	2.46e-05	0.000198	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ABCB1—esophageal cancer	2.44e-05	0.000197	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALDOB—esophageal cancer	2.42e-05	0.000195	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—EP300—esophageal cancer	2.42e-05	0.000195	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.42e-05	0.000194	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GAPDH—esophageal cancer	2.33e-05	0.000188	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CRABP1—esophageal cancer	2.31e-05	0.000186	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NOS3—esophageal cancer	2.21e-05	0.000178	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GNG7—esophageal cancer	2.2e-05	0.000177	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALDH2—esophageal cancer	2.06e-05	0.000166	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTGS2—esophageal cancer	2.02e-05	0.000162	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTT1—esophageal cancer	1.96e-05	0.000158	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP2A6—esophageal cancer	1.94e-05	0.000156	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.93e-05	0.000155	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ENO1—esophageal cancer	1.84e-05	0.000148	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTGS1—esophageal cancer	1.84e-05	0.000148	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.83e-05	0.000148	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PSME2—esophageal cancer	1.81e-05	0.000146	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PSME1—esophageal cancer	1.81e-05	0.000146	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CA—esophageal cancer	1.79e-05	0.000144	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—EP300—esophageal cancer	1.68e-05	0.000135	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CREBBP—esophageal cancer	1.63e-05	0.000131	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.58e-05	0.000127	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP1B1—esophageal cancer	1.56e-05	0.000126	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP19A1—esophageal cancer	1.47e-05	0.000118	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NOS3—esophageal cancer	1.46e-05	0.000118	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HMOX1—esophageal cancer	1.34e-05	0.000108	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTGS2—esophageal cancer	1.34e-05	0.000108	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.31e-05	0.000106	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ABCB1—esophageal cancer	1.29e-05	0.000103	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CA—esophageal cancer	1.24e-05	9.99e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—EP300—esophageal cancer	1.11e-05	8.94e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.72e-06	7.82e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CREBBP—esophageal cancer	8.59e-06	6.91e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CA—esophageal cancer	8.23e-06	6.62e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NOS3—esophageal cancer	7.69e-06	6.19e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTGS2—esophageal cancer	7.04e-06	5.66e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—EP300—esophageal cancer	5.85e-06	4.71e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CA—esophageal cancer	4.33e-06	3.48e-05	CbGpPWpGaD
